NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

33 hedge funds and large institutions have $1.05M invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$14K
Net Calls
Net Calls Change

Top Buyers

1 +$32.9K
2 +$31K
3 +$5.74K
4
Citadel Advisors
Citadel Advisors
Florida
+$4.88K
5
Morgan Stanley
Morgan Stanley
New York
+$357

Top Sellers

1 -$14K
2 -$6.98K
3 -$6.08K
4
UBS Group
UBS Group
Switzerland
-$5.41K
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$371K
2
$257K
3
$88K
4
$81K
5
$52K
6
$33K
7
$27K
8
$25K
9
$15K
10
$15K
11
$14K
12
$13K
13
$11K
14
$11K
15
$7K
16
$4K
17
$4K
18
$3K
19
$3K
20
$2K
21
$2K
22
$2K
23
$2K
24
$1K
25
$1K